You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 270 No. 24, December 22, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Host Factors Related to Poor Immunogenicity of Hepatitis B Vaccine in Adults

Another Reason to Immunize Early

Harold S. Margolis, MD; Angela C. Presson, MD, PhD

JAMA. 1993;270(24):2971-2972.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Infection with hepatitis B virus (HBV) has been recognized as a significant hazard for persons with occupational exposure to blood or body fluids, and vaccination of these individuals has been recommended by the Immunization Practices Advisory Committee of the US Public Health Service.1 Following licensure of hepatitis B vaccine in late 1981, programs to vaccinate health care workers were found primarily in larger hospitals, and the highest vaccination rates were in those hospitals that paid for this cost-effective prevention measure.2 However, in 1985 it was estimated that fewer than 25% of health care workers had been vaccinated.2 In 1991, the Occupational Safety and Health Administration (OSHA) issued regulations to ensure protection of workers from the hazards of infection with bloodborne pathogens, which included requiring employers to provide hepatitis B vaccination.3 Because the proposed requirements were widely announced as part of the rule-making process of the Department . . . [Full Text PDF of this Article]


Author Affiliations

From the Division of Viral and Rickettsial Diseases, Hepatitis Branch, Centers for Disease Control and Prevention, Atlanta, Ga (Dr Margolis), and the Office of Occupational Medicine, Occupational Safety and Health Administration, US Department of Labor, Washington, DC (Dr Presson).


Footnotes

Reprint requests to Division of Viral and Rickettsial Diseases, Hepatitis Branch, Centers for Disease Control and Prevention, Bldg 6, Room 154, Mailstop A-33, Atlanta, GA 30333 (Dr Margolis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.